CSF1R and Alzheimer disease: One is a mixed inhibitor of both CSF1R and tropomyosin receptor kinases B and C (Trk B/C) [20], while the second ([11C]JHU11744) has shown promise in preliminary evaluation in rodent models of AD and neuroinflammation [21].